PhRMA Challenges 340B Program Dispute Resolution Final Rule
- January 29, 2021
The Pharmaceutical Research and Manufacturers of America (PhRMA) is challenging a final rule issued in the waning days of the Trump administration that establishes a binding alternative dispute resolution (ADR) process to resolve disputes under the 340B Drug Discount Program.
ARTICLE TAGS
You must be logged in to access this content.